British American Tobacco (BAT) has again bet on the cannabis industry as it looks to diversify its portfolio as part of its plan to transition to a smoke-free future.
After increasing its stake in Canada’s CBD firm Organigram in April, the tobacco giant has now entered the European cannabis market, leading a $37.6m investment round into Germany’s medical cannabis business Sanity.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.